EXPT
EXPARTE APPEAL TERMINATED
03/22/2022
Back to search
Official data from USPTO
PRECISION FOR MEDICINE BIOSPECIMEN SOLUTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PRECISION FOR MEDICINE BIOSPECIMEN SOLUTIONS
ST13
US500000088578766Class
1, 39, 42, 44
Filing
88578766
Registration
6680003
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
03/22/2022
Trademark type
Word
Nice classes
1, 39, 42, 44
Filing date
08/14/2019
Registration date
03/22/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/22/2022
Last transaction
03/22/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/01/2020
First use in commerce
05/01/2020
Drawing code
4
Owner type
16
Owner location
Bethesda, MD, US
Examiner
BROOKSHIRE, DAVID AARON
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Precision Medicine Group, LLC
Representatives
Donna H. Hartman OlenderFeldman LLP
Technical classification
Nice Classes
Class 1Class 39Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological tissuebloodblood plasmablood serumhuman tissuesglands and organs for use in scientific and medical research
Class 39
Distribution servicesdelivery of biological tissue specimens for medical and scientific research purposes; biomedical servicesstorage of human biological specimensbloodblood serumtissuesglands and organs for scientific and medical research use; shipping and packing of biological specimens; storage of human biological specimens for use in medical researchdevelopment and clinical trials conducted by companies in the in-vitro diagnosticspharmaceutical and biotechnology industries
Class 42
Operating and maintaining a biorepository for medical and scientific research purposes; medical and scientific laboratory servicesanalysis and characterization of biological tissue samples; clinical trial management services for the in-vitro diagnosticspharmaceutical and biotechnology industriesthe collection and handling of human biological specimens for use in medical researchdevelopment and clinical trials conducted by companies in the in-vitro diagnosticspharmaceutical and biotechnology industries
Class 44
Tissue bank services; medical consulting services in the fields of surgery and pathology
Publications
History of USPTO decisions and trademark events.
45 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/22/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/12/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/20/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/13/2022
EXPI
EX PARTE APPEAL-INSTITUTED
01/13/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
01/13/2022
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
01/13/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/13/2021
GNFR
FINAL REFUSAL E-MAILED
07/13/2021
CNFR
SU - FINAL REFUSAL - WRITTEN
07/13/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/14/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/11/2021
GNRT
NON-FINAL ACTION E-MAILED
06/11/2021
CNRT
SU - NON-FINAL ACTION - WRITTEN
06/11/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/21/2021
GNRT
NON-FINAL ACTION E-MAILED
04/21/2021
CNRT
SU - NON-FINAL ACTION - WRITTEN
04/21/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/08/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/08/2021
IUAF
USE AMENDMENT FILED
02/18/2021
EISU
TEAS STATEMENT OF USE RECEIVED
02/18/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/04/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/04/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/23/2020
PUBO
PUBLISHED FOR OPPOSITION
06/23/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/03/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/18/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2020
ALIE
ASSIGNED TO LIE
05/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/05/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/05/2019
GNRT
NON-FINAL ACTION E-MAILED
11/05/2019
CNRT
NON-FINAL ACTION WRITTEN
11/05/2019
DOCK
ASSIGNED TO EXAMINER
10/26/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/29/2019
NWAP
NEW APPLICATION ENTERED
08/17/2019
Continuous trademark protection
Get notified about every new filing that threatens PRECISION FOR MEDICINE BIOSPECIMEN SOLUTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.